News and Press Releases

SeaBeLife secures €2 million

This funding will help fast-track the launch of clinical trials in dry AMD and severe acute hepatitis programs 1 October 2025 -- Roscoff, France -- SeaBeLife, a biotechnology company developing...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025

Place Georges Teissier 29680 ROSCOFF

PACE launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health

1 October 2025 -- Alderley Park, UK -- To stay ahead of the escalating antibiotic resistance crisis, we need bold thinking and transformative innovation. According to the World Health Organization...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025

Rezon Bio launches as a European biologics CDMO combining cost efficiency and digital innovation.

New brand with proven track record – EMA and FDA-audited mirrored-capability sites in Poland provide an accelerated path from development to commercialization 29 September 2025 -- Gdańsk, Poland -- Rezon...

Category: BioManufacturing, Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: September 29, 2025

Trzy Lipy 3, Building A 80-172 Gdansk, Poland

eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading Cell and Gene Therapy services in Southeast Asia

23 September 2025 -- Bristol, UK and Bangkok, Thailand -- eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical company...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: September 23, 2025

Britannia Road, Patchway, Bristol, BS34 5TA

Upperton Pharma Solutions Advancing Oral Vaccines Delivery with Oxford’s Pandemic Sciences Institute

14 August 2025 -- Nottingham, UK -- Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: August 14, 2025

Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

At BIO Show in Boston, PCI Pharma Services to Provide Updates on New Manufacturing Facility at Nearby Bedford, NH Campus

For leading CDMO, qualification activities for plant’s state-of-the-art sterile fill-finish and lyophilization line are underway, with GMP production commencing summer 2025 6 June 2025 -- Pennsylvania, US -- PCI Pharma Services, a world...

Category: BioManufacturing, Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: June 6, 2025

3001 Red Lion Road, Philadelphia, PA 19114, USA

Bionova Scientific Licenses ATUM’s Proprietary Transposon-Based Gene Delivery Technology to Accelerate & De-Risk Cell Line Development

7 May 2025 -- California, US and Düsseldorf, Germany -- Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has licensed ATUM’s...

Category: Biotechnology, Drug Discovery, Manufacturing and Packing, Pharmaceutical
Posted: May 7, 2025

3288 Laurelview Ct. Fremont, CA 94538

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges

Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery systems like prefilled syringes and cartridges, and biologics – including high potent assets for antibody-drug...

Category: Manufacturing and Packing, Pharmaceutical
Posted: May 1, 2025

3001 Red Lion Road, Philadelphia, PA 19114, USA

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high potent formulations such as ADCs, complementing existing global sterile...

Category: Logistics, Manufacturing and Packing, Pharmaceutical
Posted: April 24, 2025

3001 Red Lion Road, Philadelphia, PA 19114, USA

Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing

Bioxodes raises €2.7 million from existing investors in Series A extension Interim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial in Q1 2025 Recruitment of up to 16 additional...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 12, 2025

Parc d'activités Aéropole Rue Santos-Dumont, 1 6041 Gosselies, Belgique

ProBioGen Launches New Website to Enhance User Experience and Streamline Access to Expanded

February 04, 2025 – Berlin, Germany – Biotech Newswire / -- ProBioGen has launched its new, redesigned website to provide biotech and biopharma professionals with clear access to its expanded...

Category: Biotechnology
Posted: February 5, 2025

Herbert-Bayer-Straße 8 13086 Berlin

Rentschler Biopharma announces strategic realignment of its global business operations

30 January 2025 – Laupheim, Germany – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations...

Category: BioManufacturing
Posted: January 30, 2025

Erwin-Rentschler-Str. 21 88471 Laupheim Germany

ENEA-Tech Biomedical Foundation Invests €6m in BetaGlue® Therapeutics

Brings 2024 Funding Round Total to €24m 16 December 2024 -- Milan, Italy -- BetaGlue Therapeutics S.p.A, an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: December 16, 2024

BetaGlue Therapeutics SpA. Piazzetta Umberto Giordano 4, 20122 Milan, Italy

Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company

12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and General Inception, a US-based venture studio, today announced a collaboration...

Category: Drug Discovery, Other
Posted: December 12, 2024

Recipharm’s full range Oral Solid Dosage (OSD) capabilities meet growing industry demands

Full range OSD development and manufacturing capabilities from orphan drugs to blockbusters High potency manufacturing capabilities expansion Introduction of ReciPredict platform to accelerate product development and de-risk tech transfer API...

Category: Manufacturing and Packing
Posted: November 19, 2024